Do we need to treat cirrhotic PVT, and how? – #EASL2025
🗣️ @jcgarciapagan
📍 LT candidate → anticoagulate if >25%
🚫 No LT → consider if >50%
🔍 Anticoagulation may help beyond recanalization
🛠️ Radiological Rx: for LT candidates not responding or with refractory CSPH
What's the deal with pain control in #cirrhosis?
A #meded#tweetorial with QI undertones
Aims:
👍Tylenol
👎NSAIDs (mostly)
🤯Pharmacokinetics in ESLD
🔪Tramadol
If this is a confusing topic for you, you are not alone!
Join me as we try 2 sort a few things out
#livertwitter
Congratulations Dr Adele Mourad Winner of Dr Falk/BASL/BLT Quality & Service Improvement Award 2023 @adele_mourad@UHSussex Dr Mourad led the UH Sussex team project ‘Engaging the disengaged to achieve Hepatitis C Virus (HCV) elimination’ View project talk: https://t.co/M9vNjblx6h
Many congratulations to Dr Adele Mourad, CNS Karrina Goodwin & Dr Laura Burke for their team awards for the 1st Dr Falk/BASL/BLT Awards for Qual Service Improvement & Innovation in #liverdisease Awards on Thursday night @basl_events@LiverTrust
The NHS is set to eliminate hepatitis C in England by 2025 — ahead of the rest of the world and the @WHO 2030 target — thanks to excellent work with partners like @StMungos.
The NHS hepatitis C elimination programme has helped find and cure over 80,000 people. #WorldHepatitisDay
@lukemparkes Gosh!! Luke I remember your first one. The length of the to do list! Im afraid ive got a few more years until i get that feeling. Congrats luke.
Less than 2 weeks to the @basl_events EOL SIG
Fantastic programme (below) and free!
am: focus on @REDUCe2study
pm: symptom control in advanced liver disease
FTF or virtual places
Still time to register - email [email protected]
Please RT and forward to anyone interested
Sunita Verma presents final results from the ITREAT study - shifts in patient characteristics undergoing HCV treatment between first and last 4 years, nice demonstration that these don't impact on SVR in the context of nurse led outreach treatment.